Retatrutide Side Effects: What to Know About the Experimental Weight Loss Injection
Discover the potential retatrutide side effects, including nausea, fatigue, anxiety, skin sensations and urinary problems. Learn about safety concerns and the risks of unlicensed weight loss injections.
Introduction
Retatrutide is an experimental weight loss medication attracting significant attention because of its potential to help people achieve substantial weight reduction. Sometimes referred to online as the “Godzilla” weight loss jab, the drug is being investigated for its ability to influence appetite, metabolism and body weight.
However, alongside interest in its potential benefits, concerns about retatrutide side effects are growing. Researchers have analysed thousands of social media posts in which people claimed to have used the drug, identifying reports of symptoms ranging from nausea and tiredness to anxiety, unusual skin sensations and urinary problems.
These findings have raised important questions about the safety of experimental weight loss injections, particularly products sold through unofficial online channels. Understanding the limitations of the available evidence is essential before drawing conclusions about this emerging treatment.
What Is Retatrutide and How Does It Work?
Retatrutide is an investigational medication being developed to support weight management and improve certain metabolic health outcomes. Unlike some existing weight loss injections, it targets three hormone-related pathways involved in regulating appetite, digestion and energy balance.
These pathways involve:
- GLP-1: A hormone pathway associated with appetite regulation, insulin release and slower stomach emptying.
- GIP: A hormone pathway involved in insulin regulation and metabolic processes.
- Glucagon: A hormone that helps regulate blood glucose and plays a role in energy metabolism.
By acting on these three pathways, retatrutide aims to reduce appetite and influence how the body manages energy.
Clinical research has reported promising weight loss results, with some participants experiencing substantial reductions in body weight. However, retatrutide remains an experimental medicine and should not be treated as an established, routinely authorised weight loss treatment.
Its potential benefits must be considered alongside the need for further safety data and appropriate regulatory review.
What Are the Potential Retatrutide Side Effects?
A study published in JAMA Network Open examined social media discussions to explore the symptoms people associated with retatrutide use.
Researchers reviewed 148,640 Reddit posts related to the drug and identified 13,589 individuals who claimed to have used it. More than half of this group reportedly described at least one adverse effect.
The findings included several commonly discussed symptoms.
1. Nausea and Digestive Problems
Digestive symptoms were among the reported concerns. These included nausea, abdominal discomfort, constipation and diarrhoea.
Such symptoms are also associated with other medications that affect GLP-1 pathways, partly because these treatments can slow stomach emptying and influence digestive function.
Although digestive problems are not unusual with certain weight loss medications, persistent vomiting, severe abdominal pain or signs of dehydration should never be ignored.
2. Fatigue and Sleep Disturbances
Tiredness was another frequently reported complaint, affecting approximately 15% of the self-reported users analysed in the study.
Insomnia was also mentioned, with around 6.1% reporting difficulty sleeping.
Fatigue and disrupted sleep can affect concentration, mood and everyday activities. However, the social media analysis cannot establish whether retatrutide directly caused these symptoms or whether other factors contributed.
3. Increased Appetite and Food Cravings
Interestingly, increased appetite was the most frequently reported change in the analysis, affecting 1,336 individuals.
This finding may appear surprising because retatrutide is being developed partly to help regulate appetite and support weight loss. Some users also described food cravings, while a smaller proportion reported unexpected weight gain.
These observations do not establish that the medication routinely increases appetite. Differences in dosage, individual responses, product authenticity and other circumstances could potentially influence the experiences reported.
4. Anxiety and Panic Attacks
Some people described psychological symptoms, including anxiety, panic attacks and depressive feelings.
Approximately 3.8% of the users in the analysis reported anxiety, while fewer than 1% reported panic attacks. Other posts mentioned depression or anhedonia, which refers to a reduced ability to experience pleasure in activities that were previously enjoyable.
These reports are important signals for further investigation, but they do not prove that retatrutide causes psychiatric conditions. Controlled clinical studies are needed to understand whether a direct relationship exists.
Anyone experiencing severe anxiety, significant mood changes or thoughts of self-harm should seek appropriate professional support.
5. Burning Skin Sensations and Urinary Problems
The analysis also identified reports of unusual skin sensations, including burning feelings, alongside urinary and kidney-related complaints.
Fifty-five users reportedly described a burning sensation in the skin, while 139 reported renal or urinary disorders.
These symptoms deserve attention, but their causes remain uncertain. Researchers could not verify the medical histories of the people posting online or confirm that the products they used actually contained retatrutide.
Consequently, these findings should be interpreted as reported symptoms requiring further investigation, rather than confirmed adverse effects of the medication.
Why Unlicensed Retatrutide Products Are a Concern
One of the biggest concerns surrounding retatrutide is its reported availability through unofficial online sellers and social media platforms.
Because the medicine is experimental, products marketed as retatrutide outside authorised research settings may not meet the safety, quality and manufacturing standards expected of regulated medicines.
A product purchased online might contain the wrong substance, an incorrect concentration, harmful contaminants or no active ingredient at all.
Using an unverified injectable product can expose people to unpredictable risks, including medication-related complications, infection and harm associated with incorrect dosing.
Packaging that looks professional does not guarantee authenticity. Consumers should not rely on photographs, seller reviews or appearance alone to determine whether an injection is genuine.
The safest approach is to avoid unlicensed weight loss injections and discuss evidence-based treatment options with a qualified healthcare professional.
What Does the Research Actually Tell Us?
The findings highlight the potential value of monitoring patient experiences outside traditional clinical trials. Social media discussions can help researchers identify symptoms that warrant closer examination.
However, there are important limitations.
First, the reports were self-submitted and were not independently verified. Second, researchers could not confirm the ingredients, quality or dosage of the products used. Third, underlying medical conditions, other medicines and lifestyle factors could have influenced the symptoms.
The study therefore cannot establish that retatrutide caused the reported problems or determine how frequently these symptoms occur among people receiving a verified product in a controlled clinical trial.
The results should be viewed as an early safety signal, not a definitive list of proven retatrutide side effects.
Is Retatrutide Safe to Use?
The safety of retatrutide is still being evaluated through clinical research. Until the relevant regulatory authorities have assessed the evidence and authorised the medicine for appropriate use, consumers should not assume that it is safe or suitable for self-treatment.
People seeking help with obesity or weight management should speak with a healthcare professional about authorised treatments, nutritional support, physical activity and other appropriate options.
If you have already used a product sold as retatrutide and develop concerning symptoms, contact a healthcare professional promptly. Seek emergency medical assistance for severe symptoms, such as difficulty breathing, collapse or severe and persistent abdominal pain.
Do not assume that serious symptoms are a normal part of weight loss treatment.
Conclusion
Retatrutide has attracted attention because of its potential to deliver significant weight loss, but important questions about its safety remain unanswered.
An analysis of Reddit posts identified reports of digestive problems, fatigue, increased appetite, anxiety, sleep disturbances, burning skin sensations and urinary complaints. These findings highlight areas for further investigation, but they do not confirm that retatrutide caused the symptoms.
The risks associated with unlicensed and potentially counterfeit injections make caution particularly important. Until stronger evidence and appropriate regulatory authorisation are available, people should avoid products sold through unofficial channels and seek professional guidance about safe, evidence-based weight management.
Ultimately, promising weight loss results should never come at the expense of personal safety.
Sources
- JAMA Network Open. Research examining patient-reported adverse events associated with retatrutide through social media analysis.
- The Sun. Health news report by Eliza Loukou, published 15 October 2026, covering reported retatrutide side effects and concerns about unlicensed products.
- US Food and Drug Administration (FDA). Information on unapproved GLP-1 drugs and the risks associated with unapproved or illegally marketed medications.
- UK Medicines and Healthcare products Regulatory Agency (MHRA).
Medical Disclaimer
This article is for informational and educational purposes only and does not constitute medical advice, diagnosis or treatment. The reported symptoms discussed above are based on observational social media research and should not be interpreted as confirmed adverse effects or proof of causation. Retatrutide is an investigational medicine, and its regulatory status may change as evidence develops. Always consult a qualified healthcare professional before making decisions about weight loss treatments or medications. Do not purchase or use unlicensed injectable medicines.